New drug may slow the progression of chronic kidney disease in type 2 diabetics, increase kidney function and stave off dialysis.

Published in Focus on Patient Care

With the acquisition, UAB takes a significant step toward making sophisticated cell therapy a part of patient care.

Published in Focus on Patient Care

The risk factors for stroke in the South also may be responsible for cognitive decline.

Published in Focus on Patient Care

By mapping a patient’s genome, and their tumor’s, with whole-genome sequencing, physicians can use more targeted therapies.

Published in Focus on Patient Care

Tigatuzumab, developed at UAB with Daiichi-Sankyo, targets aggressive, hard-to-treat tumors that make up 25 percent of all breast cancers

Published in Focus on Patient Care

Sleep deprivation, stress and a confused circadian clock can be a lethal combination  

Page 5 of 5
Back to Top